Independent Review Organizations (IROs): Role in Insurance Appeals

Independent Review Organizations (IROs) are accredited third-party entities authorized to conduct binding external reviews of insurance coverage denials. This page covers how IROs are defined under federal and state law, the mechanics of the external review process, the types of disputes where IRO review applies, and the boundaries of what an IRO can and cannot decide. Understanding IRO authority is foundational to navigating the external review process in insurance and exercising full appeal rights under applicable law.

Definition and Scope

An Independent Review Organization is an entity that employs or contracts with licensed, board-certified clinical reviewers — typically physicians or other credentialed health professionals — to evaluate whether a health insurer's denial of coverage is consistent with medical evidence and applicable clinical standards. IROs function as a neutral adjudicator that is structurally independent from both the insurer and the enrollee.

Federal authority for IRO use comes from the Affordable Care Act (ACA), specifically 42 U.S.C. § 300gg-19, which requires non-grandfathered group health plans and individual health insurance plans to provide access to an external review process meeting minimum federal standards. The Department of Health and Human Services (HHS), the Department of Labor (DOL), and the Department of the Treasury jointly administer these requirements for different plan types under Technical Release 2010-01 and subsequent guidance.

States operate parallel accreditation and assignment frameworks. The National Association of Insurance Commissioners (NAIC) developed the Uniform Health Carrier External Review Model Act, which at least 29 states have adopted in some form. Under state law, insurance commissioners maintain lists of approved IROs, and assignment of a specific IRO to a dispute is typically randomized to prevent insurer influence over panel selection.

IROs are distinct from internal appeal reviewers hired by the insurer. Accreditation of IROs is conducted by independent bodies such as URAC (formerly the Utilization Review Accreditation Commission), which sets organizational, staffing, and conflict-of-interest standards. URAC's IRO accreditation standards require that reviewers have no financial stake in the outcome and no material affiliation with the plan being reviewed.

For employer-sponsored plans governed by ERISA, federal external review standards apply directly where state insurance law does not govern the plan. Self-insured ERISA plans that are not subject to state mandates must still comply with the federal external review process established by DOL guidance.

How It Works

The IRO process follows a defined procedural sequence once the internal appeals stage has been exhausted or, in urgent cases, bypassed.

1. Eligibility determination. The enrollee or plan participant requests external review. The insurer reviews whether the denial involves an adverse benefit determination eligible for external review — generally any denial based on medical necessity, appropriateness, setting, level of care, or effectiveness. Pure contract interpretation disputes (e.g., a plan exclusion for a specific non-medical service) may be excluded.

2. Request submission. The request is submitted to the insurer or directly to the state insurance department, depending on jurisdiction. Under the federal process, requests must typically be filed within 4 months of the final internal denial notice (45 C.F.R. § 147.136).

3. IRO assignment. The insurer or state commissioner assigns the case to an IRO from the approved list, generally on a rotating or random basis to prevent selection bias.

4. Record transmission. The insurer transmits the complete claim file, denial rationale, and any clinical guidelines cited. The enrollee may submit additional medical records, treating physician statements, or research-based literature.

5. Clinical review. A qualified reviewer — matched to the clinical specialty at issue — evaluates the submission against evidence-based standards. qualified professionals must hold an active license and have no conflict of interest with either party.

6. Decision issuance. The IRO issues a written decision, typically within 45 calendar days for standard reviews and 72 hours for expedited reviews under the federal framework. The decision is binding on the insurer.

For urgent circumstances, expedited external review can run concurrently with the internal appeal process, compressing the timeline to protect access to time-sensitive care.

Common Scenarios

IRO review is most frequently requested in three categories of disputes:

Medical necessity denials. These are the most common IRO cases. The insurer determines that a requested service, procedure, or hospitalization does not meet its definition of medical necessity. The IRO reviewer evaluates the denial against research-based clinical literature and specialty society guidelines. Medical necessity appeals that reach IRO review are overturned at rates that vary substantially by plan type and service category, according to data published by state insurance departments.

Experimental and investigational treatment denials. Insurers routinely deny coverage for treatments classified as experimental. IRO reviewers assess whether the denial correctly applies the plan's experimental treatment definition against current clinical evidence. This category is addressed in detail at experimental treatment appeals.

Level-of-care and site-of-service disputes. A plan may approve a service but deny coverage at the requested setting — for example, inpatient versus outpatient psychiatric care. IRO reviewers apply clinical criteria such as the InterQual or Milliman Care Guidelines to assess whether the level of care was appropriate.

Out-of-network and prior authorization disputes. Denials arising from prior authorization failures or out-of-network billing disputes may qualify for IRO review when the underlying denial basis is clinical rather than purely contractual.

Decision Boundaries

IRO authority is broad within the clinical domain but has defined limits that enrollees and plan administrators must understand.

What IROs can decide:

• Whether the denial is consistent with evidence-based clinical standards
• Whether the insurer applied its own coverage criteria correctly in a medical necessity context
• Whether an experimental classification is supported by current clinical evidence
• Whether the level or setting of care was clinically appropriate

What IROs cannot decide:

• Contract interpretation questions outside the clinical domain. If a plan explicitly excludes a category of service by name (e.g., cosmetic surgery), and the dispute is purely whether the procedure falls within that exclusion, IRO authority may not apply. This distinction is addressed in the NAIC Model Act commentary.
• ERISA benefit structure claims. IROs cannot adjudicate disputes about plan design, premium disputes, or eligibility determinations unrelated to clinical criteria.
• Bad faith conduct. Allegations that an insurer acted in bad faith require separate legal action and fall outside IRO jurisdiction.
• Non-health lines. IRO review as defined under federal ACA and state external review statutes applies to health insurance. Property, auto, life, and disability lines use different dispute mechanisms. See types of insurance appeals for a cross-line comparison.

A key distinction exists between standard external review and expedited external review. Standard review applies to non-urgent medical situations and allows the fuller 45-day timeline. Expedited review applies when the standard timeline would seriously jeopardize the enrollee's life, health, or ability to regain maximum function, or when the denial concerns an admission, continued stay, or emergency service. The IRO decision in either track is binding on the health plan, though the enrollee retains the right to pursue insurance litigation after a failed appeal on procedural or legal grounds separate from the clinical merits.

Plans that fail to comply with a binding IRO decision may face regulatory enforcement by state insurance commissioners or, for ERISA plans, by the DOL's Employee Benefits Security Administration (EBSA). The insurance appeals process overview situates IRO review within the broader sequence of internal and external remedies available to policyholders.

References

• 42 U.S.C. § 300gg-19 — External Appeals (ACA), Cornell Law School Legal Information Institute
• 45 C.F.R. § 147.136 — Internal Claims and Appeals and External Review, eCFR (HHS)
• DOL Technical Release 2010-01 — External Review Guidance, Department of Labor EBSA
• NAIC Uniform Health Carrier External Review Model Act (#75), National Association of Insurance Commissioners
• URAC IRO Accreditation Standards, URAC (formerly Utilization Review Accreditation Commission)
• HHS — External Appeals: Summary of ACA Requirements, CMS
• DOL Employee Benefits Security Administration — Claims and Appeals, Department of Labor